Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Praticien-chercheur
14 articles scientifiques publiés — formation continue solide
Expérience confirmée
27 ans d'exercice en rhumatologie — recul clinique solide
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
27ans d'exercice (thèse 1999)
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
19
19 articles ont été cités au moins 19fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
2 036
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
60
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
27
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
The Needs of Patients with Psoriasis and Benefits of Apremilast in French Clinical Practice: Results from the Observational REALIZE Study
2023ArticleDermatology and Therapy
Moderate Psoriasis in Clinical Practice: French Expert Consensus Using a Modified Delphi Method
2022ArticleAdvances in Therapy
The role of exposome in acne: results from an international patient survey
2019ArticleJournal of the European Academy of Dermatology and Venereology
The influence of exposome on acne
2018ArticleJournal of the European Academy of Dermatology and Venereology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CDS MEDICAL ST JACQUES
37 R DES VOLONTAIRES, 75730 PARIS CEDEX 15
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of dermatological science · 2017
International journal of dermatology · 2006
AbstractBackground Facial appearance plays a large role in self‐perception and interaction with others. Visible facial skin lesions are a common condition.Purpose This study assessed factors associated with health‐related quality of life (HRQOL) in women with visible facial skin lesions.Methods The study included 73 women with one or more of the following conditions: acne, dermatosis papulosis, hypopigmentation, lentigenes, melasma, rosacea, vascular proliferations and other facial scars. The Skindex‐16 was used as a measure of HRQOL. Fear of negative evaluation (FNE) was assessed to determine whether self‐perception characteristics relate to HRQOL.Results There were strong correlations in both bivariate and multivariate analyses among increased FNE, heightened perception of QOL without the facial condition and lower overall HRQOL (P < 0.05 and P < 0.01, respectively). There were no differences in HRQOL by type of facial condition, as well as no effects of the area covered by the condition on HRQOL. Interestingly, women not using foundations represented only 10% of the study population and had better HRQOL than women who did use foundations.Conclusions Severe facial blemishes of any cause have a significant impact on women's QOL, and the effect of these lesions is mediated in part by psychological characteristics related to self‐perception and self‐presentation.
Photodermatology, photoimmunology & photomedicine · 2017
SummaryBackgroundUntil now, photoprotection of human skin has involved the development of sunscreens effective in the ultraviolet (UV) domain. During the last ten years, several studies have shown that besides the well‐known damaging effects of UV, visible (400‐700 nm) and even infrared light (> 700 nm) can induce damage which contributes to photoaging. Furthermore, many photodermatoses are also known to be triggered by visible light (VL).Objective/MethodAn in vivo method is proposed to assess the protective efficacy of sunscreens in the VL domain. This method is based on the intensity of pigmentation induced by four repeated daily doses of VL, each equivalent to about one hour of midday sun. Exposures are performed using a solar simulator (xenon lamp) equipped with appropriate filters, and pigmentation is measured both clinically and by chromametry. Three commercially available sunscreens designed to protect in the visible range were evaluated.ResultsThe results indicate that the VL‐induced pigmentation was already significantly detectable visually and by chromametry 24 hours after the first exposure on the unprotected zone. Two products with moderate protective activity could be differentiated from the untreated zone from Day 3 to Day 5 and were also significantly less effective than a third tested product within the same study period.ConclusionThe method is simple, based on a clinical end point of VL‐induced skin pigmentation, and can be performed within a 5‐day period. It allows discrimination between products of different protective capacities. VL protection factor is also discussed.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Dermatology and therapy · 2023 · Published Erratum
Jullien D, Richard MA, Halioua B, Bessette C, et al.
Dermatology and therapy · 2023 · Journal Article
Jullien D, Richard MA, Halioua B, Bessette C, et al.
Photodermatology, photoimmunology & photomedicine · 2017 · Comparative Study
Duteil L, Esdaile J, Maubert Y, Cathelineau AC, et al.
Journal of dermatological science · 2017 · Journal Article
Krutmann J, Bouloc A, Sore G, Bernard BA, et al.
European journal of dermatology : EJD · 2015 · Case Reports
Dreno B, Bettoli V, Perez M, Bouloc A, et al.
Photodermatology, photoimmunology & photomedicine · 2014 · Journal Article
Jeanmougin M, Bouloc A, Schmutz JL
Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology · 2012 · Journal Article
Ascher B, Fanchon C, Kanoun-Copy L, Bouloc A, et al.
Cutis · 2005 · Journal Article
Balkrishnan R, McMichael AJ, Hu JY, Camacho FT, et al.
Acta dermato-venereologica · 2017 · Journal Article
Bouloc A, Roo E, Moga A, Chadoutaud B, et al.
Journal of cosmetic dermatology · 2015 · Comparative Study
Bouloc A, Vergnanini AL, Issa MC
Journal of cosmetic dermatology · 2022 · Journal Article
Massiot P, Clavaud C, Thomas M, Ott A, et al.
International journal of dermatology · 2006 · Journal Article
Balkrishnan R, McMichael AJ, Hu JY, Camacho FT, et al.
Advances in therapy · 2022 · Journal Article
Richard MA, Aubin F, Beneton N, Bouloc A, et al.
Acta dermatovenerologica Alpina, Pannonica, et Adriatica · 2011 · Journal Article
Bartenjev I, Oremović L, Rogl Butina M, Sjerobabski Masnec I, et al.